会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • System for controlled release of biologically active compounds
    • 用于控制释放生物活性化合物的系统
    • US4933185A
    • 1990-06-12
    • US223887
    • 1988-07-11
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • Margaret A. WheatleyRobert S. LangerHerman N. Eisen
    • A61K9/16A61K9/50A61K9/62
    • A61K9/1664A61K9/1652A61K9/5031Y10S514/885Y10S514/963Y10T428/2984Y10T428/2985
    • A controlled release system for delivery of a biologically-active substance. In one embodiment, there is a delayed release of a biologically-active substance. In a second embodiment, the delayed release is preceded by an initial release of biologically active substance. In other variations of the system, there are mulitple discrete releases over time or a continuous slow release combined with discrete releases. The delayed exposure is achieved through the design and construction of the system, specifically, formation of ionically-coated microcapsules around the biologically-active substance in conjunction with a microcapsule core-degrading enzyme. Release of active substance takes place in a burst at such a time as the core degrading enzyme has reduced the core to a molecular weight too low to support enough interaction with the cationic skin to maintain its integrity as a skin. In one example, microcapsules are formed of an ionically cross-linked polysaccharide, calcium alginate, which is further ionically coated with a poly-cationic skin of poly-L-lysine. The capsule coating serves a dual purpose: to control diffusion of the biologically-active substance and the core-degrading enzyme and as a substrate for the mechanism by which the biologically-active substance is released after a time delay.
    • 用于递送生物活性物质的控制释放系统。 在一个实施方案中,存在生物活性物质的延迟释放。 在第二个实施方案中,延迟释放之前是生物活性物质的初始释放。 在系统的其他变体中,随着时间的推移有多种离散的释放,或者连续的缓慢释放与离散的释放相结合。 延迟曝光是通过系统的设计和构建来实现的,具体地说,在微生物活性物质周围与微胶囊核心降解酶结合形成离子涂覆的微胶囊。 活性物质的释放在核心降解酶已经将核心降低到分子量太低以至于不能支持与阳离子皮肤的足够相互作用以维持其作为皮肤的完整性的时候发生。 在一个实例中,微胶囊由离子交联的多糖,藻酸钙形成,其进一步离子地涂覆有聚-L-赖氨酸的多阳离子皮肤。 胶囊涂层具有双重目的:控制生物活性物质和核心降解酶的扩散,并且作为延迟后释放生物活性物质的机制的底物。